TONY AKPENGBE: Open Payments
NPI 1437441524 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 4 companies in 2025. Trend: 2023 $141 · 2024 $34 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| ABBVIE INC. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, Auvelity, UZEDY.
Industry payments across CA — which companies pay providers there.
